Wellington Management Group LLP Cuts Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Wellington Management Group LLP cut its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 8.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,462,339 shares of the company's stock after selling 591,060 shares during the period. Wellington Management Group LLP owned approximately 2.62% of HCA Healthcare worth $1,939,671,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. D.A. Davidson & CO. lifted its stake in HCA Healthcare by 61.3% during the 3rd quarter. D.A. Davidson & CO. now owns 4,042 shares of the company's stock worth $1,643,000 after acquiring an additional 1,536 shares in the last quarter. Townsquare Capital LLC boosted its stake in shares of HCA Healthcare by 12.8% in the third quarter. Townsquare Capital LLC now owns 2,687 shares of the company's stock valued at $1,092,000 after purchasing an additional 305 shares during the period. Glenmede Trust Co. NA increased its stake in HCA Healthcare by 4.4% during the 3rd quarter. Glenmede Trust Co. NA now owns 3,022 shares of the company's stock worth $1,228,000 after buying an additional 128 shares during the period. Financial Counselors Inc. boosted its position in HCA Healthcare by 3.0% in the 3rd quarter. Financial Counselors Inc. now owns 1,551 shares of the company's stock valued at $630,000 after buying an additional 45 shares during the period. Finally, Rockefeller Capital Management L.P. raised its stake in shares of HCA Healthcare by 1.9% in the third quarter. Rockefeller Capital Management L.P. now owns 23,090 shares of the company's stock valued at $9,380,000 after acquiring an additional 440 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Price Performance

Shares of HCA stock traded down $16.61 during trading hours on Friday, hitting $332.53. The company's stock had a trading volume of 2,518,277 shares, compared to its average volume of 1,361,332. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The stock has a market cap of $81.87 billion, a price-to-earnings ratio of 15.14, a P/E/G ratio of 1.10 and a beta of 1.68. The business has a fifty day moving average of $327.23 and a 200-day moving average of $339.87.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period last year, the business posted $5.90 EPS. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.87%. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. The ex-dividend date was Monday, March 17th. HCA Healthcare's payout ratio is presently 13.11%.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.30% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on HCA shares. Cantor Fitzgerald reissued an "overweight" rating and set a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. JPMorgan Chase & Co. restated a "neutral" rating and issued a $380.00 price objective on shares of HCA Healthcare in a report on Tuesday, December 17th. Truist Financial dropped their target price on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Bank of America dropped their price objective on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a report on Monday, January 27th. Finally, Morgan Stanley lowered their price target on HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating for the company in a report on Tuesday, December 17th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.